Early research (Phase 1)Study completedNCT00000810
What this trial is testing
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120